These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Topical cream-based oxyresveratrol in the treatment of cutaneous HSV-1 infection in mice. Lipipun V; Sasivimolphan P; Yoshida Y; Daikoku T; Sritularak B; Ritthidej G; Likhitwitayawuid K; Pramyothin P; Hattori M; Shiraki K Antiviral Res; 2011 Aug; 91(2):154-60. PubMed ID: 21669230 [TBL] [Abstract][Full Text] [Related]
3. The efficacy of antiviral antibiotic 17997 on treatment of HSV-1 infected guinea pig skin infection. Tao P; Wang S; Leng Q Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Jun; 14(2):125-7. PubMed ID: 11503040 [TBL] [Abstract][Full Text] [Related]
4. Value of the dorsal cutaneous guinea pig model in selecting topical antiviral formulations for the treatment of recurrent herpes simplex type 1 disease. Poli G; Dall'Ara P; Binda S; Santus G; Poli A; Cocilovo A; Ponti W Arzneimittelforschung; 2001; 51(5):433-8. PubMed ID: 11413746 [TBL] [Abstract][Full Text] [Related]
5. Acyclovir treatment of cutaneous herpes in guinea pigs and herpes encephalitis in mice. Collins P; Oliver NM Am J Med; 1982 Jul; 73(1A):96-9. PubMed ID: 7102714 [TBL] [Abstract][Full Text] [Related]
6. Topical acyclovir for herpes simplex. Med Lett Drugs Ther; 1982 Jun; 24(611):55-6. PubMed ID: 7087887 [No Abstract] [Full Text] [Related]
7. Pathogenicity and response to topical antiviral therapy in a murine model of acyclovir-sensitive and acyclovir-resistant herpes simplex viruses isolated from the same patient. Lebel A; Boivin G J Clin Virol; 2006 Sep; 37(1):34-7. PubMed ID: 16781887 [TBL] [Abstract][Full Text] [Related]
8. Effect of acyclovir on acute and latent herpes simplex virus infections in the rabbit. Trousdale MD; Dunkel EC; Nesburn AB Invest Ophthalmol Vis Sci; 1980 Nov; 19(11):1336-41. PubMed ID: 7429768 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic effects of foscarnet sodium and acyclovir on cutaneous infections due to herpes simplex virus type 1 in guinea pigs. Alenius S; Berg M; Broberg F; Eklind K; Lindborg B; Oberg B J Infect Dis; 1982 Apr; 145(4):569-73. PubMed ID: 6279738 [TBL] [Abstract][Full Text] [Related]
10. Chemotherapeutic efficacy of E-5-(2-bromovinyl)-2'deoxyuridine for orofacial infection with herpes simplex virus type 1 in mice. Park NH; Pavan-Langston D; Boisjoly HM; De Clercq E J Infect Dis; 1982 Jun; 145(6):909-13. PubMed ID: 6979592 [TBL] [Abstract][Full Text] [Related]
11. Cutaneous herpes simplex virus infections. Arbesfeld DM; Thomas I Am Fam Physician; 1991 May; 43(5):1655-64. PubMed ID: 1826983 [TBL] [Abstract][Full Text] [Related]
12. Acyclovir treatment of experimental genital herpes simplex virus infections. Kern ER Am J Med; 1982 Jul; 73(1A):100-8. PubMed ID: 6285699 [TBL] [Abstract][Full Text] [Related]
13. Limited efficacy of inhibitors of herpes simplex virus DNA synthesis in murine models of recrudescent disease. Kristofferson A; Ericson AC; Sohl-Akerlund A; Datema R J Gen Virol; 1988 Jun; 69 ( Pt 6)():1157-66. PubMed ID: 2838569 [TBL] [Abstract][Full Text] [Related]
14. Treatment of Herpes simplex virus infections with topical antiviral agents. Hamuy R; Berman B Eur J Dermatol; 1998; 8(5):310-9. PubMed ID: 9683881 [TBL] [Abstract][Full Text] [Related]
15. Early intervention with high-dose acyclovir treatment during primary herpes simplex virus infection reduces latency and subsequent reactivation in the nervous system in vivo. Sawtell NM; Thompson RL; Stanberry LR; Bernstein DI J Infect Dis; 2001 Oct; 184(8):964-71. PubMed ID: 11574910 [TBL] [Abstract][Full Text] [Related]
16. Influence of the treatment protocol upon the in vivo efficacy of cidofovir (HPMPC) and of acyclovir (ACV) formulations in topical treatment of cutaneous HSV-1 infection in hairless mice. Afouna MI; Mehta SC; Ghanem AH; Higuchi WI; Kern ER; DeClercq E; El-Shattawy HH J Pharm Sci; 1999 May; 88(5):530-4. PubMed ID: 10229644 [TBL] [Abstract][Full Text] [Related]